To explore the temporal characteristics and influencing factors of the two distinct phases in the diabetic retinopathy (DR) diagnosis process, aiming to enhance patient outcomes.
Approach:
Key Findings:
The study identifies two critical phases in the DR diagnosis process: the asymptomatic phase and the symptomatic phase, highlighting the need for targeted interventions.
Patients often delay seeking medical attention after the onset of ocular symptoms, which can lead to poorer disease awareness and increased socioeconomic burden, underscoring the need for awareness campaigns.
A significant association exists between diabetes duration and the development of DR, with ≥ 10 years indicating higher risk, suggesting the need for early monitoring.
Interpretation:
Understanding the distinct phases of the DR diagnosis process can help optimize screening strategies and improve early diagnosis workflows, ultimately leading to better patient outcomes.
Limitations:
The study may not account for all socioeconomic and healthcare accessibility factors influencing diagnosis timelines, which could introduce bias.
Data was collected from a specific geographic area, which may limit generalizability to other regions.
Conclusion:
Identifying critical time windows in DR diagnosis is essential for reducing visual impairment and improving patient outcomes, emphasizing the need for timely interventions.
An artificial intelligence–based optical coherence tomography pathway met noninferiority criteria for false-positive diabetic macular edema referrals and was associated with fewer referral decisions in a randomized clinical trial.
A nationwide Swedish cohort found a higher relative risk of anterior ischemic optic neuropathy among GLP-1 receptor agonist users, but the overall risks were low.
